Accelevation Holdings director purchases 10,000 shares
Director Ginger M. Jones of Accelevation Holdings Corp. acquires 10,000 shares at $18 each, signaling confidence in the company's future.
Accelevation Holdings COO Reports Significant Stock Transactions
Accelevation Holdings Corp. COO Jewell Brent C. reports major stock transactions, signaling growth in the electrical industrial apparatus sector.
Chafey Diana Reports Stock Transactions at Hagerty, Inc.
Chafey Diana, Chief Legal Officer at Hagerty, Inc., disclosed stock transactions, indicating ongoing engagement with the company's equity and confidence in its future.
Houston Andrew reports stock transactions in SEC filing
Houston Andrew details stock transactions in SEC filing, reflecting strategic moves within the company and potential industry impacts.
Hendricks Lloyd Bernard III Reports Major Share Transactions
Hendricks Lloyd Bernard III discloses significant transactions affecting his ownership in MineralRite Corp, impacting the miscellaneous metal ores sector.
New Oriental Education to Host Annual General Meeting in November
New Oriental Education & Technology Group Inc. announces its annual general meeting for November 13, 2026, with no proposals for shareholder approval.
Aya Gold & Silver Reports Record Q3 2026 Production Results
Aya Gold & Silver Inc. achieves record Q3 2026 silver production of 2.03 million ounces, reflecting strong operational performance and growth potential.
Ferrari announces €101.5 million share buyback program update
Ferrari N.V. reports on its €250 million share buyback program, purchasing €101.5 million in shares as part of a larger €3.5 billion initiative.
Quartz Mountain Resources Closes $1.7 Million Financing
Quartz Mountain Resources Ltd. has closed a $1.7 million financing to enhance its exploration efforts in British Columbia's mining sector.
Freight Technologies announces share exchange agreements
Freight Technologies, Inc. restructures its capital by exchanging preferred shares for ordinary shares, impacting its financial flexibility.
Coca-Cola Europacific Partners confirms share buyback program
Coca-Cola Europacific Partners plc confirms share buyback, purchasing 138,046 shares in the U.S. and 49,900 in London as part of its strategy.
Novo Nordisk launches DKK 15 billion share repurchase program
Novo Nordisk A/S announces a share repurchase program worth DKK 15 billion, reflecting confidence in financial strength and enhancing shareholder value.
STMicroelectronics announces share buyback results for October
STMicroelectronics N.V. reports on its recent share buyback program, acquiring 492,285 shares to enhance shareholder value.
Mako Mining Reports Strong Q3 2026 Production Results
Mako Mining Corp. announces Q3 2026 production results, highlighting significant gold recovery and permitting updates, signaling growth in the gold and silver industry.
EShallGo Inc. announces share consolidation to meet Nasdaq rules
EShallGo Inc. has approved a share consolidation to comply with Nasdaq listing rules, reducing outstanding shares significantly.
Prudential PLC Announces Share Buyback of Over 2.4 Million
Prudential PLC has repurchased 2.4 million shares as part of its ongoing buyback program, reinforcing its commitment to returning value to shareholders.
BBVA executes second tranche of share buyback program
BBVA has completed the second tranche of its share buyback program, purchasing shares worth approximately 79 million euros, enhancing shareholder value.
Uni-Fuels Holdings raises $3 million in commercial paper offering
Uni-Fuels Holdings Ltd successfully raised $3 million through its Series 006 commercial paper offering, signaling a shift in financing strategies in the industry.
IRSA Investments repurchases $9 million in Series XXV Notes
IRSA Investments & Representations Inc. repurchases $9 million of its Series XXV Notes, representing 18% of the total outstanding amount.
Scinai Immunotherapeutics closes $4 million financing deal
Scinai Immunotherapeutics Ltd. has closed a $4 million financing through a private placement to enhance its contract development and immunotherapy programs.